CD79A and inflammatory bowel disease: Only the London cohort demonstrated significantly less frequent aGP23 IgG in PSC patients with concomitant IBD and the Hamburg cohort significantly less frequent aGP22 IgA in patients with UC (p < 0.05, respectively) (Table 3).